Codes / ICD10CM / D64.0

D64.0 Hereditary sideroblastic anemia

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Hereditary sideroblastic anemia
  • ICD Code: D64.0

Summary

Hereditary sideroblastic anemia is a rare genetic disorder characterized by the body's inability to properly incorporate iron into hemoglobin, leading to the accumulation of iron in red blood cell precursors (sideroblasts) in the bone marrow. This results in ineffective erythropoiesis and anemia, with symptoms ranging from mild to severe depending on the specific genetic mutation and individual factors.

Causes

The condition is caused by genetic mutations that affect heme synthesis or iron metabolism in red blood cell production. These mutations disrupt the normal process of iron utilization, leading to the formation of ringed sideroblasts and impaired hemoglobin synthesis. Inherited in an X-linked or autosomal dominant/recessive pattern, the specific genetic defects vary by subtype.

Risk Factors

  • Family history of sideroblastic anemia
  • X-linked inheritance patterns (more common in males for certain subtypes)
  • Genetic mutations in genes involved in heme synthesis (e.g., ALAS2, SLC25A38)
  • Certain ethnic or familial backgrounds with known prevalence

Symptoms

  • Fatigue and weakness due to anemia
  • Shortness of breath, especially with exertion
  • Pale or jaundiced skin
  • Dizziness or lightheadedness
  • Enlarged spleen (splenomegaly) in some cases
  • Iron overload symptoms (e.g., organ damage) if untreated

Diagnosis

Diagnosis involves a complete blood count (CBC) to identify anemia and abnormal red blood cell morphology, followed by bone marrow aspiration and biopsy to detect ringed sideroblasts. Additional tests may include genetic sequencing to identify specific mutations, serum iron studies, and evaluation of heme synthesis pathways. Peripheral blood smears may show hypochromic, microcytic, or normocytic red blood cells.

Treatment Options

  • Regular blood transfusions to manage severe anemia
  • Iron chelation therapy to prevent or treat iron overload
  • Pyridoxine (vitamin B6) supplementation, which may improve symptoms in some subtypes
  • Management of underlying genetic causes where possible
  • Supportive care for symptoms, such as folic acid supplementation

Prognosis and Follow-Up

Prognosis varies depending on the severity of the anemia, response to treatment, and presence of complications like iron overload. Regular monitoring of hemoglobin levels, iron stores, and organ function is essential. Long-term follow-up may involve managing iron overload to prevent liver, heart, or endocrine damage. Early intervention can improve quality of life, but some subtypes may progress to more severe disease.

Complications

  • Iron overload (hemochromatosis) leading to organ damage
  • Increased risk of infections due to impaired red blood cell function
  • Splenomegaly and associated complications
  • Potential progression to myelodysplastic syndromes or leukemia in rare cases

Lifestyle & Prevention

  • Avoid unnecessary iron supplementation unless prescribed
  • Follow a balanced diet to support overall health
  • Regular medical check-ups to monitor iron levels and organ function
  • Genetic counseling for families with a history of the condition

When to Seek Professional Help

Seek medical attention if experiencing persistent fatigue, shortness of breath, or unexplained weakness. Prompt evaluation is necessary if symptoms worsen or if there are signs of iron overload, such as abdominal pain, joint pain, or changes in skin color. Regular follow-up with a hematologist is recommended for ongoing management.

Tips for Medical Coders

When coding for hereditary sideroblastic anemia (D64.0), ensure documentation supports the hereditary nature of the condition, including family history, genetic testing results, or clinical features consistent with inherited sideroblastic anemia. Differentiate from acquired forms by verifying the absence of secondary causes (e.g., toxin exposure, medication effects) unless documented. Code D64.0 is specific to hereditary cases; do not use it for acquired sideroblastic anemia, which may require a different code.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

D64.0 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.